Prevention of migraines (New form of botox)

A new form of Botox that could relieve your migraines

Migraine is one of the leading causes of the disease burden with approximately 1 billion people worldwide affected, making migraine the third prevalent disease and the second most disabling neurological condition in terms of years lost as a disability. in the world.

Women are disproportionately affected by migraine, at a rate about 3 times that of men.

In addition, 85% of people who have chronic migraines are women.

Migraine is a neurological disorder characterized by throbbing headache attacks and neurological symptoms such as nausea, vomiting, hypersensitivity to environmental stimuli, and mood changes.

Attacks can last between 4 hours and 72 hours and can dramatically impair functional ability at work, school, home, and in social situations.

The development and course of migraine differs from person to person, where some experience an increase in frequency over a period of months or years and may gradually change from low-frequency episodic migraine to episodic migraine. high frequency, then chronic migraine.

Treatments for times of crisis and preventatives are used to treat migraines.

As people with migraine switch from treatment with a lower frequency to a higher frequency, the importance of preventive treatments may become more part of the overall approach.

One of these preventative treatments is botox injection.

The present phase 2 clinical study aims to evaluate the effectiveness of a new form of botox for the prevention of migraine headaches.

To participate, you must:

• Be 18 years of age and over
• Have been diagnosed with migraine for at least 1 year
• Have 6 or more migraines per month

You will be given reimbursement for study-related expenses when you participate in the clinical study and you will be surrounded by a medical team throughout the process.